---
company: Innventure, Inc.
ticker: INV
form: 8-K
filed: 2026-08-13
accession: 0002001557-26-000152
source: https://www.sec.gov/Archives/edgar/data/2001557/000200155726000152/
---

# Innventure (INV) earnings release, August 13, 2026

Innventure, Inc. (INV) · Form 8-K, Item 2.02 · Filed 2026-08-13 · [SEC filing](https://www.sec.gov/Archives/edgar/data/2001557/000200155726000152/)

Innventure Reports Second Quarter 2026 Results

Accelsius focused on execution against foundational milestones to strengthen path to scaled two-phase adoption

ORLANDO, Fla., August 13, 2026 (GLOBAL NEWSWIRE) – Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today announced financial results for the quarter ended June 30, 2026.

The company continues to anticipate significant long‑term demand for two‑phase liquid cooling as AI infrastructure requirements accelerate and is focused on executing against the foundational milestones expected to govern scaled market adoption of this technology. These milestones include chip-maker relationships and reference designs, OEM and ODM co-development initiatives, relationships with hyperscalers and the delivery of additional thermal benchmark data.

“We firmly believe the industry is moving toward a future where two-phase liquid cooling becomes an essential part of AI infrastructure,” said Bill Haskell, Chief Executive Officer. “While our conviction in Accelsius’ long‑term opportunity has only strengthened, evolving dynamics in the AI infrastructure market, including constraints facing smaller early adopters around power availability, GPU access, and deployment timing, have impacted our near-term expectations and render 2026 revenue generation an imprecise reflection of the meaningful progress Accelsius is making. As a result, we are suspending our previously communicated expectations regarding Accelsius’ 2026 revenue and cash flow targets and shifting our focus to execution against important milestones that govern scaled market adoption, which include forging strong relationships with industry leaders. In light of our expectations regarding Accelsius’ ability to make progress against these milestones and the momentum we are seeing at AeroFlexx and Refinity, we believe Innventure is well positioned to create shareholder value over the long term."

Conference Call and Webcast

A conference call to discuss these results has been scheduled for 5:00 pm ET today, August 13, 2026.

The event will be webcasted live via our investor relations website https://ir.innventure.com/ or via https://innventure-2q26-earnings.open-exchange.net/.

Innventure has posted a slide presentation to accompany the prepared remarks to its investor relations website https://ir.innventure.com/.

About Innventure

Innventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, focuses on building companies with billion-dollar valuations by commercializing breakthrough technology solutions. By systematically creating and operating industrial enterprises from the ground up, Innventure participates in early-stage economics and provides industrial operating expertise designed for global scale. Innventure’s approach seeks to uniquely bridge the ”Valley of Death" between corporate innovation and commercialization through its distinctive combination of value-driven multinational partnerships, operational experience, and scaling expertise.

Non-GAAP Financial Measures

We use certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. (GAAP) to supplement our consolidated financial statements. These non-GAAP financial measures provide additional information to investors to facilitate comparisons of past and present operating results, identify trends in our underlying operating performance, and offer greater transparency on how we evaluate our business activities. These measures are integral to our processes for budgeting, managing operations, making strategic decisions, and evaluating our performance.

Our primary non-GAAP financial measures are EBITDA and Adjusted EBITDA. We define EBITDA as net income before interest, income taxes, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA further adjusted to exclude certain non-cash items, non-recurring expenses, and other items that are not indicative of our core operating activities. These may include stock-based compensation, acquisition costs, and other financial items. We believe Adjusted EBITDA is valuable for investors and analysts as it provides additional insight into our operational performance, excluding the impacts of certain financing, investing, and other non-operational activities. This measure helps in comparing our current operating results with prior periods and with those of other companies in our industry. It is also used internally for allocating resources efficiently, assessing the economic outcomes of acquisitions and strategic decisions, and evaluating the performance of our management team.

There are limitations to Adjusted EBITDA, including its exclusion of cash expenditures, future requirements for capital expenditures and contractual commitments, and changes in or cash requirements for working capital needs. Adjusted EBITDA also omits significant interest expenses and related cash requirements for interest and payments. While depreciation and amortization are non-cash charges, the associated assets will often need to be replaced in the future, and Adjusted EBITDA does not reflect the cash required for such replacements. Additionally, Adjusted EBITDA does not account for income or other taxes or necessary cash tax payments.

Investors should use caution when comparing our non-GAAP measure to similar metrics used by other companies, as definitions can vary. Adjusted EBITDA should not be considered in isolation or as a substitute for GAAP financial measures.

In presenting Adjusted EBITDA, we aim to provide investors with an additional tool for assessing the operational performance of our business. It serves as a useful complement to our GAAP results, offering a more comprehensive understanding of our financial health and operational efficiencies.

Cautionary Statement Regarding Forward-Looking Statements... (truncated)of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are often identified by future or conditional words such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “will,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on the current assumptions and expectations of future events that are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this press release. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

These risks and uncertainties include, but are not limited to, those factors described in Innventure’s public filings with the U.S. Securities and Exchange Commission, including but not limited to the following: Innventure’s and its subsidiaries’ ability to execute on their strategies, book sales and achieve future financial performance; developments and projections relating to Innventure’s and its subsidiaries’ competitors and industry; the implementation, adoption, market acceptance and success of Innventure’s and its subsidiaries’ products, business models and growth strategies; Innventure’s and its subsidiaries’ ability to generate sufficient revenue and operating cash flow; the timing and magnitude of expected cash expenditures; the availability, timing and terms of additional financing, including debt or equity financing; market conditions affecting access to capital; potential dilution resulting from future financings; Innventure’s ability to successfully implement cost reduction initiatives; changes in economic conditions; competitive pressures; regulatory developments; Innventure’s ability to maintain control over its subsidiaries.

Forward‑looking statements speak only as of the date of this release, and Innventure undertakes no obligation to update them except as required by law.

Investor Relations Contact:

Kyle Nagarkar, Solebury Strategic Communications investorrelations@innventure.com

Media Contact:

Stephanie Knight, Solebury Strategic Communications press@innventure.com

Innventure, Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

Innventure, Inc. and Subsidiaries

Consolidated Statements of Operations and Comprehensive Income (Loss)

(in thousands, except share and per share amounts)

Innventure, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

Innventure, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

Innventure, Inc. and Subsidiaries

Non-GAAP Financial Measures

(in thousands)

(1) Interest Expense, net, includes interest incurred on our various borrowing facilities and the amortization of debt issuance costs.

(2) Change in fair value of financial liabilities – For the three and six months ended June 30, 2026, and 2025, the change in fair value of financial liabilities primarily consists of the change in fair value of the warrant liability, the earnout liability and the embedded derivatives in various instruments.

(3) Stock based compensation – For the three and six months ended June 30, 2026, and 2025, stock based compensation primarily consisted of awards in the 2024 Equity and Incentive Plan. These awards consisted of Stock Options, Restricted Stock Units, and Stock Appreciation Rights. Further, a portion of this expense was related to share-based payment employee incentive plans in existence at subsidiaries.

(4) Goodwill impairment - For the three and six months ended June 30, 2025, the Company recognized goodwill impairment due to sustained decreases in the Company’s publicly quoted share price and market capitalization, which were, at least in part, sensitive to the general downward volatility experienced in the stock market in the comparable period in the prior year. There was no goodwill impairment for the three and six months ended June 30, 2026.

(5) Loss on extinguishment of debt - For the six months ended June 30, 2026, the Company repaid the Convertible Debentures, which resulted in an aggregate of

$1.0 million loss on extinguishment of debt. There was no loss on extinguishment of debt for the three months ended June 30, 2026. For the three and six months ended June 30, 2025, the Company recognized a loss on extinguishment of debt of $3.5 million in connection with the modification of the WTI Facility.

(6) Loss on extinguishment of related party debt - For the six months ended June 30, 2025, the Company extinguished certain related party debts by issuing Series C Preferred Stock. There was no loss on extinguishment of related party debt for the three months ended June 30, 2026.

## Financial statements

### Income Statement (Three Months Ended June 30, 2026 — (in thousands, except share and per share amounts))

| | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---:|---:|---:|---:|
| Revenue | 953 | 476 | 2,396 | 700 |
| Operating Expenses | Cost of sales | 5,073 | 2,861 | 10,326 | 3,045 |
| Operating Expenses | General and administrative | 14,499 | 18,569 | 27,249 | 38,245 |
| Operating Expenses | Sales and marketing | 3,089 | 2,208 | 5,986 | 4,304 |
| Operating Expenses | Research and development | 9,780 | 6,068 | 17,620 | 12,321 |
| Operating Expenses | Goodwill impairment |  | 113,344 |  | 346,557 |
| Operating Expenses | Total Operating Expenses | 32,441 | 143,050 | 61,181 | 404,472 |
| Operating Expenses | Loss from Operations | -31,488 | -142,574 | -58,785 | -403,772 |
| Non-operating (Expense) and Income | Interest expense, net | -531 | -2,647 | -1,520 | -4,185 |
| Non-operating (Expense) and Income | Net gain (loss) from investments | 39 |  | 108 |  |
| Non-operating (Expense) and Income | Change in fair value of financial liabilities | -2,188 | 7,176 | -2,125 | 23,605 |
| Non-operating (Expense) and Income | Equity method investment (loss) income | -1,491 | -1,924 | -3,007 | -8,680 |
| Non-operating (Expense) and Income | Realized gain on conversion of available for sale investment |  |  |  | 1,507 |
| Non-operating (Expense) and Income | Loss on extinguishment of debt |  | -3,462 | -977 | -3,462 |
| Non-operating (Expense) and Income | Loss on extinguishment of related party debt |  |  |  | -3,538 |
| Non-operating (Expense) and Income | Miscellaneous other expense | -773 | -64 | -948 | -43 |
| Non-operating (Expense) and Income | Total Non-operating Income (Expense) | -4,944 | -921 | -8,469 | 5,204 |
| Non-operating (Expense) and Income | Loss before Income Taxes | -36,432 | -143,495 | -67,254 | -398,568 |
| Non-operating (Expense) and Income | Income tax benefit | -1,518 | -2,220 | -4,557 | -3,619 |
| Non-operating (Expense) and Income | Net Loss | -34,914 | -141,275 | -62,697 | -394,949 |
| Less: net loss attributable to | Non-redeemable non-controlling interest | -8,411 | -57,048 | -15,389 | -167,725 |
| Less: net loss attributable to | Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | -26,503 | -84,227 | -47,308 | -227,224 |
| Less: net loss attributable to | Basic and diluted loss per share | -0.32 | -1.6 | -0.59 | -4.6 |
| Less: net loss attributable to | Basic and diluted weighted average common shares | 83,117,031 | 52,546,491 | 83,117,031 | 49,417,092 |

### Income Statement (Three Months Ended June 30, 2026 — (in thousands))

| | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---:|---:|---:|---:|
| Net loss | -34,914 | -141,275 | -62,697 | -394,949 |
| Interest expense, net(1) | 531 | 2,647 | 1,520 | 4,185 |
| Depreciation and amortization expense | 5,660 | 5,634 | 11,331 | 11,182 |
| Income tax expense (benefit) | -1,518 | -2,220 | -4,557 | -3,619 |
| EBITDA | -30,241 | -135,214 | -54,403 | -383,201 |
| Change in fair value of financial liabilities(2) | 2,188 | -7,176 | 2,125 | -23,605 |
| Stock-based compensation(3) | 5,477 | 9,406 | 10,309 | 15,247 |
| Goodwill impairment(4) |  | 113,344 |  | 346,557 |
| Loss on extinguishment of debt(5) |  | 3,462 | 977 | 3,462 |
| Loss on extinguishment of related party debt(6) |  |  |  | 3,538 |
| Adjusted EBITDA | -22,576 | -16,178 | -40,992 | -38,002 |

### Balance Sheet (June 30, 2026 — (in thousands, except share amounts))

| | June 30, 2026 | December 31, 2025 |
|---|---:|---:|
| Assets | Cash and cash equivalents | 41,543 | 60,449 |
| Assets | Restricted cash | 5,000 | 5,000 |
| Assets | Accounts receivable | 2,119 | 1,094 |
| Assets | Due from related parties | 16,351 | 11,840 |
| Assets | Inventories | 2,989 | 1,604 |
| Assets | Prepaid expenses and other current assets | 3,437 | 3,167 |
| Assets | Total Current Assets | 71,439 | 83,154 |
| Assets | Investments | 26,644 | 28,741 |
| Assets | Property, plant and equipment, net | 2,269 | 1,941 |
| Assets | Intangible assets, net | 149,729 | 160,537 |
| Assets | Goodwill | 323,463 | 323,463 |
| Assets | Other assets | 1,153 | 1,351 |
| Assets | Total Assets | 574,697 | 599,187 |
| Liabilities and Stockholders' Equity | Accounts payable | 1,932 | 2,551 |
| Liabilities and Stockholders' Equity | Accrued employee benefits | 4,977 | 11,343 |
| Liabilities and Stockholders' Equity | Accrued expenses | 1,959 | 7,386 |
| Liabilities and Stockholders' Equity | Contract liabilities | 534 | 947 |
| Liabilities and Stockholders' Equity | Notes payable - current | 7,700 | 12,846 |
| Liabilities and Stockholders' Equity | Term convertible note, current | 8,026 | 7,890 |
| Liabilities and Stockholders' Equity | Convertible promissory note, current | 4,407 | 4,331 |
| Liabilities and Stockholders' Equity | Patent installment payable - current | 825 | 700 |
| Liabilities and Stockholders' Equity | Obligation to issue equity | 73 | 119 |
| Liabilities and Stockholders' Equity | Warrant liability | 28,683 | 27,458 |
| Liabilities and Stockholders' Equity | Income taxes payable | 18 | 23 |
| Liabilities and Stockholders' Equity | Other current liabilities | 633 | 682 |
| Liabilities and Stockholders' Equity | Total Current Liabilities | 59,767 | 76,276 |
| Liabilities and Stockholders' Equity | Notes payable, net of current portion | 5,909 | 8,327 |
| Liabilities and Stockholders' Equity | Earnout liability | 4,790 | 3,890 |
| Liabilities and Stockholders' Equity | Stock-based compensation liability | 213 | 239 |
| Liabilities and Stockholders' Equity | Patent installment payable, net of current | 11,550 | 12,375 |
| Liabilities and Stockholders' Equity | Deferred income taxes | 9,264 | 13,848 |
| Liabilities and Stockholders' Equity | Other liabilities | 389 | 556 |
| Liabilities and Stockholders' Equity | Total Liabilities | 91,882 | 115,511 |
| Preferred stock, $0.0001 par value, 25,000,000 shares authorized; | Common Stock, $0.0001 par value, 250,000,000 shares authorized, 84,612,657 and 67,743,847 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. | 8 | 7 |

### Cash Flow (Three Months Ended June 30, 2026 — (in thousands))

| | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---:|---:|
| Cash Flows Used in Operating Activities | Net loss | -62,697 | -394,949 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Stock-based compensation | 10,309 | 15,247 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Interest income on debt securities - related party | -180 | -195 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Change in fair value of financial liabilities | 2,125 | -23,605 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Non-cash interest expense on notes payable | 1,119 | 2,560 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Net gain on investments | -107 |  |
| Adjustments to reconcile net loss to net cash used in operating activities: | Accrued unpaid interest on note payable | 238 |  |
| Adjustments to reconcile net loss to net cash used in operating activities: | Equity method investment loss (income) | 3,006 | 8,680 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Realized gain on conversion of available for sale investments |  | -1,507 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Loss on extinguishment of debt | 977 | 3,462 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Loss on extinguishment of related party debt |  | 3,538 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Deferred income taxes | -4,585 | -3,897 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Loss on Disposal of PPE | 223 |  |
| Adjustments to reconcile net loss to net cash used in operating activities: | Depreciation and amortization | 11,331 | 11,182 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Goodwill impairment |  | 346,557 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Other costs, net | 1,100 | 165 |
| Changes in operating assets and liabilities: | Accounts receivable | -1,025 | -618 |
| Changes in operating assets and liabilities: | Prepaid expenses and other current assets | -4,779 | -3,312 |
| Changes in operating assets and liabilities: | Inventory | -1,385 | -1,442 |
| Changes in operating assets and liabilities: | Accounts payable | -619 | 315 |
| Changes in operating assets and liabilities: | Accrued employee benefits | -6,365 | 1,330 |
| Changes in operating assets and liabilities: | Accrued expenses | -6,722 | 42 |
| Changes in operating assets and liabilities: | Stock-based compensation liability | -26 | -686 |
| Changes in operating assets and liabilities: | Income taxes payable | -5 | 292 |
| Changes in operating assets and liabilities: | Other current liabilities | -286 | -78 |
| Changes in operating assets and liabilities: | Contract liabilities | -413 | 690 |
| Changes in operating assets and liabilities: | Patent installment payable | -700 | -525 |
| Changes in operating assets and liabilities: | Net Cash Used in Operating Activities | -59,466 | -36,754 |
| Cash Flows (Used in) Provided by Investing Activities | Investment in available-for-sale debt securities - equity method investee |  | -2,708 |
| Cash Flows (Used in) Provided by Investing Activities | Acquisition of property, plant and equipment | -1,074 | -932 |
| Cash Flows (Used in) Provided by Investing Activities | Net Cash (Used in) Provided by Investing Activities | -1,074 | -3,640 |

### Cash Flow (Three Months Ended June 30, 2026 — (in thousands))

| | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---:|---:|
| Cash Flows Provided by Financing Activities | Proceeds from issuance of equity, net of issuance costs | 50,229 | 3,675 |
| Cash Flows Provided by Financing Activities | Proceeds from the issuance of equity to non-controlling interest, net of issuance costs |  | 5,367 |
| Cash Flows Provided by Financing Activities | Proceeds from the issuance of convertible promissory note |  | 3,999 |
| Cash Flows Provided by Financing Activities | Proceeds from the issuance of term convertible notes |  | 2,451 |
| Cash Flows Provided by Financing Activities | Proceeds from issuance of debt securities, net of issuance costs |  | 27,000 |
| Cash Flows Provided by Financing Activities | Payment of debts | -8,595 | -1,176 |
| Cash Flows Provided by Financing Activities | Distributions to Stockholders |  | -76 |
| Cash Flows Provided by Financing Activities | 41,634 | 41,240 |
| Cash Flows Provided by Financing Activities | Net Decrease in Cash, Cash Equivalents and Restricted Cash | -18,906 | 846 |
| Cash Flows Provided by Financing Activities | Cash, Cash Equivalents and Restricted Cash Beginning of period | 65,449 | 11,119 |
| Cash Flows Provided by Financing Activities | Cash, Cash Equivalents and Restricted Cash End of period | 46,543 | 11,965 |
